Germany Uterine Cancer Market Size & Outlook, 2025-2033


Germany Uterine Cancer Market Insights

  • According to Reed Intelligence analysis, the Germany Uterine Cancer Market size was USD 538.66 Million in 2024 and is projected to reach USD 857.67 Million by 2033.
  • The Germany market is projected to grow at a CAGR of 5.36% between 2026 and 2033.
  • By segment, Endometrial Adenocarcinoma emerged as the largest By Type in terms of market size in 2024.
  • Papillary Serous Carcinoma is anticipated to remain the most attractive By Type segment, recording the fastest growth during the forecast period.

Other Key Findings


  • In 2024, Germany represented 8.6% of the overall global Uterine Cancer Market size.
  • United States is projected to lead the global Uterine Cancer Market size by 2033.
  • Across Europe, Germany is anticipated to hold the dominant position in market size by 2033.
  • Germany is forecasted to expand at the fastest pace in Europe, attaining USD 861.8 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 538.66 Million
Market Size In 2033 USD 857.67 Million
Largest segment Endometrial Adenocarcinoma
Units Revenue in USD Million
CAGR 5.36% (2025-2033)
Segmnetation Covered
By Type
  1. Endometrial Adenocarcinoma
  2. Adenosquamous Carcinoma
  3. Papillary Serous Carcinoma
  4. Uterine Sarcoma
By Treatment
  1. Diagnosis
  2. Therapeutic Treatment
  3. Surgery
By End-Users
  1. Hospitals
  2. Diagnostic Centers
  3. Drug Stores
  4. Online Pharmacies
  5. Other End Users
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends